Arteris (NASDAQ:AIP) COO Laurent Moll Sells 1,003 Shares

Key Points

• COO Laurent Moll sold 1,003 shares of Arteris on April 13 at an average price of $19.90 for a total of $19,959.70, reducing his stake by 0.36% to 278,979 shares, per the SEC filing.
• Arteris shares traded up 1.8% to $20.17 on volume above average, with a 12‑month range of $5.64–$20.40 and a market cap of about $917 million.
• The company beat quarterly expectations (EPS of -$0.05 vs. -$0.08 expected and revenue $20.14M vs. $18.55M), but analysts remain mixed with a consensus "Hold" and a target price of $20.17.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) COO Laurent Moll sold 1,003 shares of Arteris stock in a transaction that occurred on Monday, April 13th. The shares were sold at an average price of $19.90, for a total transaction of $19,959.70. Following the transaction, the chief operating officer owned 278,979 shares of the company's stock, valued at $5,551,682.10. The trade was a 0.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Arteris Stock Up 1.8%

Shares of AIP stock traded up $0.35 during trading hours on Tuesday, hitting $20.17. 545,587 shares of the company's stock traded hands, compared to its average volume of 473,921. Arteris, Inc. has a 12-month low of $5.64 and a 12-month high of $20.40. The stock has a market cap of $917.13 million, a price-to-earnings ratio of -24.60 and a beta of 1.43. The stock's fifty day simple moving average is $16.03 and its two-hundred day simple moving average is $15.28.

Arteris (NASDAQ:AIP - Get Free Report) last announced its quarterly earnings data on Thursday, February 12th. The company reported ($0.05) earnings per share for the quarter, topping analysts' consensus estimates of ($0.08) by $0.03. The firm had revenue of $20.14 million during the quarter, compared to analysts' expectations of $18.55 million. On average, equities analysts forecast that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have commented on the company. Wall Street Zen upgraded Arteris from a "hold" rating to a "buy" rating in a research note on Saturday, March 21st. Rosenblatt Securities reiterated a "buy" rating and set a $20.00 target price on shares of Arteris in a research note on Friday, February 13th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Arteris in a research note on Wednesday, January 21st. Finally, Northland Securities set a $24.00 target price on Arteris in a research note on Friday, February 13th. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $20.17.

Institutional Investors Weigh In On Arteris

A number of hedge funds have recently added to or reduced their stakes in AIP. AQR Capital Management LLC purchased a new stake in Arteris during the 1st quarter valued at $1,621,000. Strs Ohio purchased a new stake in Arteris during the 1st quarter valued at $104,000. Geode Capital Management LLC raised its stake in Arteris by 4.8% during the 2nd quarter. Geode Capital Management LLC now owns 652,754 shares of the company's stock valued at $6,222,000 after buying an additional 30,018 shares during the last quarter. Rhumbline Advisers raised its stake in Arteris by 35.8% during the 2nd quarter. Rhumbline Advisers now owns 54,416 shares of the company's stock valued at $519,000 after buying an additional 14,350 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its stake in Arteris by 8.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 320,332 shares of the company's stock valued at $3,053,000 after buying an additional 25,448 shares during the last quarter. 64.36% of the stock is currently owned by hedge funds and other institutional investors.

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.